Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prem Mahendra

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Blood|August 12, 2004
Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphomaEmma Morris, Kirsty Thomson, Charles Craddock, et al.
British Journal of Haematology|April 27, 2012
Organ-specific management and supportive care in chronic graft-versus-host diseaseFiona L Dignan, Julia J Scarisbrick, Jacqueline Cornish, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Blood|August 12, 2004
Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphomaEmma Morris, Kirsty Thomson, Charles Craddock, et al.
British Journal of Haematology|April 27, 2012
Organ-specific management and supportive care in chronic graft-versus-host diseaseFiona L Dignan, Julia J Scarisbrick, Jacqueline Cornish, et al.
Pageof 2